Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cells

Nanomedicine

Volumn 6, Issue 7, 2011, Pages 1215-1230

  Haney, Matthew J ^a,b   Zhao, Yuling ^a,b   Li, Shu ^a,b   Higginbotham, Sheila M ^a,b   Booth, Stephanie L ^a,b   Han, Huai Yun ^a,b   Vetro, Joseph A ^a,b   Mosley, R Lee ^a,b,c   Kabanov, Alexander V ^a,b,d   Gendelman, Howard E ^a,b,c   Batrakova, Elena V ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

bloodbrain barrier; bone marrow derived macrophages; cell mediated drug delivery; intercellular communication; Parkinson's disease

Indexed keywords

CATALASE; LIPID; NANOPARTICLE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BONE MARROW CELL; BONE MARROW DERIVED MACROPHAGE; BRAIN CELL; BRAIN MICROVESSEL ENDOTHELIAL CELL; CELL CONTACT; CELL ENERGY; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TRANSPORT; ENDOCYTOSIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LAMELLIPODIUM; MACROPHAGE; MALE; MICROTUBULE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; BRAIN; CATALASE; CELL LINE; ENDOCYTOSIS; ENDOTHELIAL CELLS; HUMANS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NANOPARTICLES; NEUROGLIA; NEURONS; PARKINSON DISEASE;

EID: 80053122209     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.32     Document Type: Article

References (35)

1. Brinton RD: A women's health issue: Alzheimer's disease and strategies for maintaining cognitive health. Int. J. Fertil. Womens Med. 44(4), 174-185 (1999). (Pubitemid 29444626)
2. Gozes I: Neuroprotective peptide drug delivery and development: potential new therapeutics. Trends Neurosci. 24(12), 700-705 (2001). (Pubitemid 33097536)
3. Kroll RA, Neuwelt EA: Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 42(5), 1083-1099 (1998).
4. Batrakova EV, Li S, Reynolds AD et al.: A macrophage-nanozyme delivery system for Parkinson's disease. Bioconjug. Chem. 18(5), 1498-1506 (2007). (Pubitemid 47464057)
5. Brynskikh AM, Zhao Y, Mosley RL et al.: Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease. Nanomedicine (Lond.) 5(3), 379-396 (2010).
6. Zhao Y, Haney M, Klyachko N et al.: Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles. Nanomedicine (Lond.) 6(1), 25-42 (2011).
7. Hendriks JJ, Teunissen CE, De Vries HE, Dijkstra CD: Macrophages and neurodegeneration. Brain Res. Brain Res. Rev. 48(2), 185-195 (2005). (Pubitemid 40585749)
8. Vinogradov S, Bronich T, Kabanov A: Self-assembly of polyamine- poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides Bioconj. Chem. 9(6), 805-812 (1998). (Pubitemid 28542249)
9. Dou H, Destache CJ, Morehead JR et al.: Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Blood 108(8), 2827-2835 (2006).
10. Stevenson HC, Fauci AS: Purification of Human Monocytes by Counter-Current Centrifugation Elutriation. Marcel Decker Press, NY, USA (1981).
11. Weidenfeller C, Schrot S, Zozulya A, Galla HJ: Murine brain capillary endothelial cells exhibit improved barrier properties under the influence of hydrocortisone. Brain Res. 1053(1-2), 162-174 (2005). (Pubitemid 41116802)
12. Faassen F, Vogel G, Spanings H, Vromans H: Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. Int. J. Pharm. 263(1-2), 113-122 (2003). (Pubitemid 37087938)
13. Langley RR, Ramirez KM, Tsan RZ, Van Arsdall M, Nilsson MB, Fidler IJ: Tissue-specific microvascular endothelial cell lines from H-2k(b)-TSA58 mice for studies of angiogenesis and metastasis. Cancer Res. 63(11), 2971-2976 (2003). (Pubitemid 36667171)
14. Batrakova E, Han H, Miller D, Kabanov A: Effects of pluronic p85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm. Res. 15(10), 1525-1532 (1998). (Pubitemid 28465737)
15. Fogh J, Fogh JM, Orfeo T: One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. Natl Cancer Inst. 59(1), 221-226 (1977). (Pubitemid 8144854)
16. Rosenbaugh EG, Roat JW, Gao L et al.: The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase. Biomaterials 31(19), 5218-5226 (2010).
17. Batrakova EV, Vinogradov SV, Robinson SM, Niehoff ML, Banks WA, Kabanov AV: Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery. Bioconjug. Chem. 16(4), 793-802 (2005). (Pubitemid 41026165)
18. Zelivyanskaya ML, Nelson JA, Poluektova L et al.: Tracking superparamagnetic iron oxide labeled monocytes in brain by high-field magnetic resonance imaging. J. Neurosci. Res. 73(3), 284-295 (2003). (Pubitemid 36918092)
19. Batrakova E, Li S, Alakhov V, Miller D, Kabanov A: Optimal structure requirements for pluronic block copolymers in modifying p-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells. J. Pharmacol. Exp. Ther. 304(2), 845-854 (2003). (Pubitemid 36152365)
20. Batrakova E, Li S, Miller D, Kabanov A: Pluronic p85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm. Res. 16(9), 1366-1372 (1999). (Pubitemid 29449372)
21. Batrakova E, Miller D, Li S, Alakhov V, Kabanov A, Elmquist W: Pluronic p85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. J. Pharmacol. Exp. Ther. 296(2), 551-557 (2001). (Pubitemid 32112485)
22. Kadiu I, Ricardo-Dukelow M, Ciborowski P, Gendelman HE: Cytoskeletal protein transformation in HIV-1-infected macrophage giant cells. J. Immunol. 178(10), 6404-6415 (2007). (Pubitemid 46717424)
23. Kadiu I, Gendelman HE: Macrophage endocytic trafficking networks facilitate HIV-1 intercellular transport through tunneling nanotubes: a novel pathway for viral dissemination. J. Immunol. (2010) (In press).
24. Krishnamurthy H, Piscitelli CL, Gouaux E: Unlocking the molecular secrets of sodium-coupled transporters. Nature 459(7245), 347-355 (2009).
25. Boyko V, Ferralli J, Ashby J, Schellenbaum P, Heinlein M: Function of microtubules in intercellular transport of plant virus RNA. Nat. Cell Biol. 2(11), 826-832 (2000).
26. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Horensavitz C, Pypaert M, Mothes W: Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat. Cell Biol. 9(3), 310-315 (2007). (Pubitemid 46344610)
27. Chinnery HR, Pearlman E, Mcmenamin PG: Cutting edge: Membrane nanotubes in vivo: a feature of MHC class II+ cells in the mouse cornea. J. Immunol. 180(9), 5779-5783 (2008).
28. Nowacek AS, Miller RL, Mcmillan J et al.: Nanoart synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery. Nanomedicine 4(8), 903-917 (2009).
29. Bressani RF, Nowacek AS, Singh S et al.: Pharmacotoxicology for monocyte-macrophage nanoformulated antiretroviral drug carriage. Nanotoxicology (2010) (Epub ahead of print).
30. Nowacek AS, McMillan J, Miller R, Anderson A, Rabinow B, Gendelman HE: Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics. J. Neuroimmune Pharmacol. 5(4), 592-601 (2010).
31. Jain S, Mishra V, Singh P, Dubey PK, Saraf DK, Vyas SP: RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting. Int. J. Pharm. 261(1-2), 43-55 (2003). (Pubitemid 36962744)
32. Dou H, Grotepas CB, McMillan JM et al.: Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroaids. J. Immunol. 183(1), 661-669 (2009).
33. Biju K, Zhou Q, Li G et al.: Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease. Mol. Ther. 18(8), 1536-1544 (2010).
34. Thery C, Ostrowski M, Segura E: Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9(8), 581-593 (2009).
35. Perry VH, Bell MD, Brown HC, Matyszak MK: Inflammation in the nervous system. Curr. Opin. Neurobiol. 5(5), 636-641 (1995).